Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of 2-[18F]FDG PET/CT in Erdheim-Chester disease.

Revista espanola de medicina nuclear e imagen molecular - 1 Jan 2000

Pudis M, Palomar-Muñoz A, Solanich-Moreno X, Robles-Barba J J, Rocamora-Blanch G, Rodríguez-Bel L, Narváez J A, Cortés-Romera M

Abstract excerpt

OBJECTIVE: To analyze the body distribution of Erdheim-Chester disease (ECD) and determine the utility of 2-[18 F]FDG PET/CT compared to other imaging techniques. Additionally, to assess the aggressiveness and extent of the disease based on the presence/absence of the BRAFV600E mutation. MATERIALS AND METHODS: The 2-[18F]FDG-PET/CT scans of all patients diagnosed with ECD between 2008 and 2021 were reviewed,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Erdheim-Chester Disease
Share to Fluorodeoxyglucose F18

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Positron-Emission Tomography

Share to Positron Emission Tomography Computed Tomography

Source

Identifiers

PMID: 37804884
DOI: 10.1016/j.remnie.2023.10.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of 2-[18F]FDG PET/CT in Erdheim-Chester disease.PMID 37804884Read ↗

18F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker.Semantic proximity Read ↗

Skeletal involvement in Erdheim-Chester disease: Multimodality imaging features and association with the BRAFV600E mutation.Semantic proximity Read ↗

[Erdheim-Chester disease initially discovered at extraskeletal locations: a clinicopathological analysis of four cases].Semantic proximity Read ↗

Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.Semantic proximity Read ↗

[Erdheim-Chester disease: a clinicopathological analysis of 16 cases].Semantic proximity Read ↗

Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib.Semantic proximity Read ↗

Sinonasal and ear manifestations of Erdheim-Chester disease.Semantic proximity Read ↗

Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAFV600E mutation.Semantic proximity Read ↗

Recent advances in therapeutic strategies of Erdheim-Chester disease.Semantic proximity Read ↗

Erdheim-Chester disease.Semantic proximity Read ↗

Erdheim-Chester disease.Semantic proximity Read ↗

Case Report: When an unknown fever unmasks Erdheim-Chester disease: a case showing the use of multimodality imaging and the successful interferon alpha therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.